TY - JOUR
T1 - Effect of Systemic Hydrocortisone Initiated 7 to 14 Days after Birth in Ventilated Preterm Infants on Mortality and Neurodevelopment at 2 Years' Corrected Age: Follow-up of a Randomized Clinical Trial
T2 - Follow-up of a Randomized Clinical Trial
AU - Halbmeijer, Nienke M.
AU - Onland, Wes
AU - Cools, Filip
AU - Swarte, Renate
AU - van der Heide-Jalving, Marja
AU - Merkus, Maruschka P.
AU - van Kaam, Anton H.
N1 - Funding Information: Funding/Support: This trial was funded by a project grant from The Netherlands Organization for Health Research and Development ZonMW Priority Medicines for Children (11-32010-02). Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/7/27
Y1 - 2021/7/27
N2 - This follow-up to the STOP-BPD randomized clinical trial, which investigated the efficacy and safety of systemic hydrocortisone treatment initiated 7 to 14 days after birth in ventilator-dependent, very preterm infants in the Netherlands and Belgium at 36 weeks’ postmenstrual age, examines the prespecified composite of death and neurodevelopmental impairment among these infants at 2 years’ corrected age.
AB - This follow-up to the STOP-BPD randomized clinical trial, which investigated the efficacy and safety of systemic hydrocortisone treatment initiated 7 to 14 days after birth in ventilator-dependent, very preterm infants in the Netherlands and Belgium at 36 weeks’ postmenstrual age, examines the prespecified composite of death and neurodevelopmental impairment among these infants at 2 years’ corrected age.
KW - Bronchopulmonary Dysplasia/prevention & control
KW - Child, Preschool
KW - Follow-Up Studies
KW - Humans
KW - Hydrocortisone/therapeutic use
KW - Infant, Newborn
KW - Infant, Premature
KW - Infant, Premature, Diseases/mortality
KW - Neurodevelopmental Disorders/epidemiology
KW - Respiration, Artificial
UR - http://www.scopus.com/inward/record.url?scp=85111634273&partnerID=8YFLogxK
U2 - https://doi.org/10.1001/jama.2021.9380
DO - https://doi.org/10.1001/jama.2021.9380
M3 - Comment/Letter to the editor
C2 - 34313697
SN - 0098-7484
VL - 326
SP - 355
EP - 357
JO - JAMA - Journal of the American Medical Association
JF - JAMA - Journal of the American Medical Association
IS - 4
ER -